Powell-Drescher Ovarian Cancer Research Foundation
@PowerOvarian
Followers
259
Following
2K
Media
47
Statuses
618
Nonprofit, powering the future of ovarian cancer research by endowing funds and championing collaboration between scientist and survivor.
Joined May 2022
Join us on Tuesday, April 22 for our inaugural Paths to Research Advocacy event - the first in a recurring series where we’ll interview experienced research advocates and scientists about their journeys to ovarian cancer research advocacy. Register through the link in our bio.
1
0
1
RT @ronny_drapkin: Something positive! We are celebrating first-author papers for @PamRdeSantiago and @Sophisticaveman with coffee mugs fro….
0
1
0
So honored to be included to share our founder’s experience.
At the #SGOMtg, @JeannieChern joined me to discuss the powerful patient stories shared during the plenary session. These testimonies highlight the lifesaving impact of clinical trials. #MoffittSGO25 . #SGO2025 #SGOAM2025 #AM25IMPACT #MultipleYourImpact @MoffittNews
0
0
0
RT @karenluMD: Sachia Powell giving an impactful speech on giving back as an ovarian cancer patient - she’s partnering and encouraging our….
0
7
0
Thank you for collaborating with survivors!.
It was amazing to have Dee Sparacio @womenofteal, Katy Loewy, and Rebecca Esparza as our patient advocates. Your stories and passion to help drive research forward really resonated with the @OvCaAcademy Early Career Investigators (ECIs), mentors, and the leadership. Thank you!.
0
0
2
So exciting to have you all there!!!.
0
0
1
RT @womenofteal: It was a pleasure to be part of the @OvCaAcademy this year. Knowing the dedication of these early career researchers gives….
0
3
0
Thrilled to have you both in Seattle!.
Wonderful to have you with us @womenofteal! You really helped the DOD OCA early career investigators appreciate the power & impact of patient advocates. TY! @bitlerlabucd @priyanka13verma @rivogel @NanZhangWistar @DenardaD @oreizes @DKhabeleMD @BuckanovichLab @PowerOvarian.
0
0
2
RT @ASCO: “Let’s be impatient for our patients.” @NCIDirector makes clear the importance of collaboration to maximize and accelerate progre….
0
5
0
Absolutely WONDERFUL to have the lay summaries - thank you @DrEricWiner and @KimmieNgMD !.
I couldn’t agree more. It was mine and @DrEricWiner’s mission last year at #ASCO23 to ask all plenary and oral abstract presentations to include lay person summaries. So important that we disseminate important data to patients! @ASCO @DanaFarber #ASCO24.
0
0
3
RT @ASCOPres: To ALL those we have lost to cancer…and to our survivors as well, in your honor, we will continue to fight cancer & comfort t….
0
45
0
RT @womenofteal: BrUOG 354 ph 2 Nivulomab alone or w ipilimumab in clear cell OC mutation -TP53 ,ARID1A PIK3CA .10% OC cells are clear cell….
0
5
0
RT @womenofteal: #ASCO24 #gyncsm .Dr Hubbard speaking on receiving information on the patient portal. improved knowledge , patients more e….
0
2
0
RT @womenofteal: Gourley discussing low grade serous OC treatments: MAPK assoc tumors better outcomes. Endocrine treatment studies being do….
0
5
0
RT @ASCOPost: Advanced Ovarian Cancer: Adding Ruxolitinib to Front-Line Neoadjuvant Chemotherapy Plus Interval Debulking Surgery https://t.….
ascopost.com
In a phase I/II NRG Oncology Group study, researchers investigated the addition of ruxolitinib to front-line paclitaxel/carboplatin neoadjuvant chemotherapy and interval debulking surgery in patients...
0
2
0
We are thrilled to announce our first Pilot Grant Award for #ovariancancer research! LOIs are due 6/15/24. $75,000 plus indirect costs up to 10%. Successful proposals must include advocate involvement in the research. For more info and to apply:
0
1
2
RT @realbowtiedoc: Dee Sparacio @womenofteal flanked by the two Gils (Gil-squared) presents #patientadvocacy as a #ovca survivor using #SoM….
0
7
0
RT @EugeniaGirda: Exciting activity in Platinum Sensitive HGS Ovarian Cancer regardless of HRD! #gynonc #ovariancancer .
0
4
0